Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Home CompaniesbiOasis Technologies Inc

biOasis Technologies Inc

Healthcare Biotechnology
PortfolioPortfolio WatchlistWatchlist
Company price
0.0001 USD 0.00(0%)
Last update at 2026-10-26T20:00:00Z
VOLUME
72935
Market Cap
0.01M

Momentum Score

…

Bioasis Technologies Inc. operates as a biopharmaceutical company. The company utilizes its proprietary xB3 platform to deliver therapeutics across the blood-brain barrier and treat central nervous system disorders in areas of high unmet medical need. Bioasis Technologies Inc. is based in New Haven, Connecticut.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.00
High
52 Week Price Range
0.00
Low
0.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
0.27M
Revenue Per Share
0.00
Gross Profit TTM
-0.70M
Debt / Equity
-
ROE
-
Net Debt
0.17M
ROCE
497.09%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-02-28 2022-02-28 2021-02-28 2020-02-29 2019-02-28
Type yearly yearly yearly yearly yearly
Date 2023-02-28 2022-02-28 2021-02-28 2020-02-29 2019-02-28
Income before tax - -2.96M 0.70M -4.06M -3.47M
Minority interest - - - - 0.00M
Net income - -2.96M 0.70M -4.06M -3.47M
Selling general administrative - 2.41M 2.46M 3.17M 4.31M
Gross profit - -0.02M 2.84M 0.61M 1.41M
Reconciled depreciation - 0.05M 0.06M 0.07M 0.07M
Ebit - -3.60M 0.38M -4.61M -6.24M
Ebitda - -3.54M 0.44M -4.54M -6.17M
Depreciation and amortization 0.17M 0.05M 0.06M 0.07M 0.07M
Non operating income net other - - - - 0.00M
Operating income - -4.89M -0.08M -5.19M -6.24M
Other operating expenses - 3.63M 3.70M 5.21M 6.28M
Interest expense - 0.65M 0.04M 0.05M 0.00M
Interest income - - - - 0.00M
Net interest income - -0.65M -0.04M -0.05M 0.00M
Extraordinary items - - - - 0.00M
Non recurring - - - - 0.00M
Other items - - - - 0.00M
Income tax expense - -0.64M -0.32M -0.55M -1.38M
Total revenue - 0.04M 4.08M 0.61M 1.42M
Total operating expenses - 3.63M 3.70M 5.21M 6.27M
Cost of revenue - 0.05M 1.24M 0.00M 0.01M
Total other income expense net - 1.86M 1.56M 0.55M 1.38M
Discontinued operations - - - - 0.00M
Net income from continuing ops - -2.96M 0.70M -4.06M -3.47M
Net income applicable to common shares - -2.96M 0.70M -4.06M -3.47M
Preferred stock and other adjustments - - - - 0.00M
Breakdown 2023-02-28 2022-02-28 2021-02-28 2020-02-29 2019-02-28
Type yearly yearly yearly yearly yearly
Date 2023-02-28 2022-02-28 2021-02-28 2020-02-29 2019-02-28
Total assets - 2.27M 3.28M 0.94M 1.74M
Intangible assets - 0.16M 0.21M 0.27M 0.33M
Other current assets - - - - 0.00M
Total liab - 4.18M 2.87M 3.43M 2.29M
Total stockholder equity - -1.92M 0.41M -2.49M -0.55M
Deferred long term liab - - - - 0.00M
Other current liab - - - - 0.26M
Common stock - 27.45M 27.26M 25.42M 24.20M
Capital stock - 27.45M 27.26M 25.42M 24.20M
Retained earnings - -40.65M -37.69M -38.39M -34.34M
Other liab - 0.79M 0.91M 0.43M 1.03M
Good will - - - - 0.00M
Other assets - - - - 0.00M
Cash - 1.73M 2.74M 0.58M 1.36M
Total current liabilities - 2.99M 1.90M 2.48M 1.26M
Net debt - 0.17M - 0.43M -
Short term debt - - - - 0.00M
Short long term debt - 1.50M 0.06M 0.49M 0.00M
Other stockholder equity - 0.18M 0.19M 0.02M 0.03M
Property plant equipment - 0.00M 0.00M 0.02M 0.03M
Total current assets - 2.11M 3.06M 0.65M 1.38M
Long term investments - - - - 0.00M
Net tangible assets - -2.08M 0.19M -2.76M -0.87M
Short term investments - - - - 0.00M
Net receivables - 0.10M 0.03M 0.01M 0.01M
Long term debt - 0.40M 0.06M 0.52M 0.00M
Inventory - - - - 0.00M
Accounts payable - 1.49M 1.84M 1.99M 1.00M
Total permanent equity - - - - 0.00M
Noncontrolling interest in consolidated entity - - - - 0.00M
Temporary equity redeemable noncontrolling interests - - - - 0.00M
Accumulated other comprehensive income - - - - 0.00M
Additional paid in capital - - - - 0.00M
Common stock total equity - - - - 0.00M
Preferred stock total equity - - - - 0.00M
Retained earnings total equity - - - - 0.00M
Treasury stock - - - - 0.00M
Accumulated amortization - - - - 0.00M
Non currrent assets other - - - - 0.36M
Deferred long term asset charges - - - - 0.00M
Non current assets total - 0.16M 0.22M 0.29M 0.36M
Capital lease obligations - - - - 0.00M
Long term debt total - - - - 0.00M
Breakdown 2023-02-28 2022-02-28 2021-02-28 2020-02-29 2019-02-28
Type yearly yearly yearly yearly yearly
Date 2023-02-28 2022-02-28 2021-02-28 2020-02-29 2019-02-28
Investments - 0.00M 0.01M 0.00M 0.39M
Change to liabilities - -0.51M 0.01M 0.74M 0.48M
Total cashflows from investing activities - - 0.01M 0.01M 0.39M
Net borrowings - 2.53M -0.58M 1.29M 1.29M
Total cash from financing activities - 2.64M 0.31M 2.49M 3.53M
Change to operating activities - 0.18M -0.24M -0.05M 0.07M
Net income - -2.96M 0.70M -4.06M -3.47M
Change in cash - -1.01M 2.16M -0.78M 0.68M
Begin period cash flow 1.73M 2.74M 0.58M 1.36M 0.68M
End period cash flow 1.73M 1.73M 2.74M 0.58M 1.36M
Total cash from operating activities - -3.64M 1.77M -3.30M -3.23M
Issuance of capital stock - 0.20M 0.19M 1.21M 3.53M
Depreciation - 0.05M 0.06M 0.07M 0.07M
Other cashflows from investing activities - - - - 0.00M
Dividends paid - - - - 0.00M
Change to inventory - 0.51M -0.01M -1.01M -0.23M
Change to account receivables - -0.07M -0.02M -0.00M 0.02M
Sale purchase of stock - - - - 0.00M
Other cashflows from financing activities - -0.09M 0.70M 1.82M 0.39M
Change to netincome - -0.98M 1.15M -0.06M -0.40M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change receivables - - - - 0.00M
Cash flows other operating - - - - 0.00M
Exchange rate changes - - - - 0.00M
Cash and cash equivalents changes - - - - 0.00M
Change in working capital - -0.40M -0.25M 0.69M 0.57M
Stock based compensation - 0.44M 0.28M 0.57M 0.98M
Other non cash items - 0.65M 0.11M 0.05M -1.38M
Free cash flow - -3.64M 1.77M -3.30M -3.23M

Peer Comparison*

Sector: Healthcare Industry: Biotechnology

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
BIOAF
biOasis Technologies Inc		 -
-%		 0.00 - - 0.03 53.47 7.72 -0.58
NVO
Novo Nordisk A/S		 -0.46
1.18%		 38.67 41.58 31.15 2.13 32.99 2.11 4.70
VRTX
Vertex Pharmaceuticals Inc		 3.54
0.68%		 521.03 30.22 24.27 10.36 6.50 9.99 24.66
REGN
Regeneron Pharmaceuticals Inc		 8.43
1.04%		 816.10 29.07 20.12 7.57 3.82 6.95 19.42
ARGNF
argenx SE		 -
-%		 790.15 45.77 31.25 13.84 7.12 11.38 36.06

Profile*

biOasis Technologies Inc

Bioasis Technologies Inc. operates as a biopharmaceutical company. The company utilizes its proprietary xB3 platform to deliver therapeutics across the blood-brain barrier and treat central nervous system disorders in areas of high unmet medical need. Bioasis Technologies Inc. is based in New Haven, Connecticut.

157 Church Street, New Haven, CT, United States, 06510

203 533 7082

https://www.bioasis.us

Name Title Year Born
Dr. Deborah Ann Rathjen B.Sc. (Hons.), FTSE, M.A.I.C.D., Ph.D., Q.C. Exec. Chairman, CEO & Pres 1958
Mr. Dave Jenkins Chief Financial Officer NA
Mr. Graeme Dick Director of Investor Relations NA
Mr. Kim Elton Director of Marketing NA
Mr. Doug Williams MBA Exec. VP & Chief Bus. Officer NA
Dr. Mei Mei Tian VP & Head of External Research NA
Dr. Deborah Ann Rathjen B.Sc. (Hons.), FTSE, M.A.I.C.D., Ph.D., Q.C. CEO & President 1958
Mr. David P. Jenkins Chief Financial Officer 1962
Mr. Aaron Elton Director of Marketing NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

BRAI
USD 3.31
+56.13%
CRML
USD 8.13
+27.43%
ENVX
USD 3.35
+25.00%
HRI
USD 156.06
+22.76%
MFIC
USD 10.26
+22.73%
AXG
USD 0.04
-25.65%
SDA
USD 0.25
-15.48%
XYL
USD 92.86
-14.21%
BA
USD 168.18
-10.69%
UNF
USD 250.40
-10.46%

Equity Sectors*

  • Basic Materials

    +1.59%

  • Communication Services

    +0.05%

  • Consumer Cyclical

    +0.14%

  • Consumer Defensive

    -0.43%

  • Energy

    -0.03%

  • Financial Services

    +0.19%

  • Financials

    -0.35%

  • Healthcare

    +1.05%

  • Industrials

    +0.67%

  • Real Estate

    -0.25%

  • Technology

    +1.31%

  • Utilities

    +0.32%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…